Atalaya Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Atalaya Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$3.6K	Hold	30,000	–	–	0.01%	68
2024 Q1	$4.8K	Hold	30,000	–	–	0.01%	84
2023 Q4	$2.4K	Hold	30,000	–	–	﹤0.01%	96
2023 Q3	$11.7K	Hold	30,000	–	–	0.01%	84
2023 Q2	$6K	Hold	30,000	–	–	﹤0.01%	132
2023 Q1	$4.2K	Hold	30,000	–	–	﹤0.01%	183
2022 Q4	$2.4K	Hold	30,000	–	–	﹤0.01%	250
2022 Q3	$5K	Hold	30,000	–	–	﹤0.01%	313
2022 Q2	$8K	Hold	30,000	–	–	﹤0.01%	279
2022 Q1	$18K	Hold	30,000	–	–	﹤0.01%	324
2021 Q4	$35K	Hold	30,000	–	–	﹤0.01%	329
2021 Q3	$35K	Buy	+30,000	New	+$37.5K	0.01%	262

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Atalaya Capital Management's NKGNW Position: Q2 2024 in Review

Atalaya Capital Management held its NKGen Biotech, Inc. Warrants (NKGNW) position steady in Q2 2024 at 30,000 shares worth $3.6K. The position accounts for 0.01% of the portfolio, ranked #68.

Atalaya Capital Management first reported a position in NKGNW in Q3 2021 and has held it in 12 quarters since. The position peaked at $35K in Q4 2021. 31 funds tracked by Wall St. Rank hold NKGNW as of Q2 2024.

Atalaya Capital Management held 30,000 shares of NKGen Biotech, Inc. Warrants worth $3.6K as of Q2 2024.
Atalaya Capital Management left its NKGen Biotech, Inc. Warrants share count unchanged in Q2 2024.
NKGen Biotech, Inc. Warrants made up 0.01% of Atalaya Capital Management's portfolio in Q2 2024, its #68 holding.
Atalaya Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and has held it in 12 quarters since.
Atalaya Capital Management's NKGen Biotech, Inc. Warrants position peaked at $35K in Q4 2021.
31 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2024.

Based on Atalaya Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.